Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.

Rocha Lima CM, Herndon JE 2nd, Kosty M, Clamon G, Green MR.

Cancer. 2002 Jan 1;94(1):181-7.

3.

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

Langer CJ, Manola J, Bernardo P, Kugler JW, Bonomi P, Cella D, Johnson DH.

J Natl Cancer Inst. 2002 Feb 6;94(3):173-81.

PMID:
11830607
5.

Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.

Berghmans T, Tragas G, Sculier JP.

Support Care Cancer. 2002 Nov;10(8):619-23. Epub 2002 Sep 4.

PMID:
12436220
6.
7.

Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR; North Central Cancer Treatment Group.

J Clin Oncol. 2005 Dec 20;23(36):9113-9.

PMID:
16361618
8.
9.

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.

Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13.

10.

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials.

Vardy J, Dadasovich R, Beale P, Boyer M, Clarke SJ.

BMC Cancer. 2009 Apr 29;9:130. doi: 10.1186/1471-2407-9-130.

11.

Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

Blackstock AW, Herndon JE 2nd, Paskett ED, Miller AA, Lathan C, Niell HB, Socinski MA, Vokes EE, Green MR; Cancer and Leukemia Group B.

J Clin Oncol. 2006 Jan 20;24(3):407-12. Epub 2005 Dec 19.

PMID:
16365181
13.

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.

Kimmick GG, Peterson BL, Kornblith AB, Mandelblatt J, Johnson JL, Wheeler J, Heinze R, Cohen HJ, Muss HB.

J Clin Oncol. 2005 Apr 1;23(10):2201-7.

PMID:
15800312
14.

A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.

Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD.

Clin Cancer Res. 2005 May 1;11(9):3342-8.

15.

Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.

Mauri D, Pentheroudakis G, Bafaloukos D, Pectasides D, Samantas E, Efstathiou E, Kalofonos HP, Syrigos K, Klouvas G, Papakostas P, Kosmidis P, Fountzilas G, Pavlidis N; Hellenic Coopeprative Oncologic Group (HeCOG).

Anticancer Res. 2006 Jul-Aug;26(4B):3175-81.

16.

Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.

Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR.

Cancer. 2005 Jun 1;103(11):2349-54.

17.

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.

Hotta K, Fujiwara Y, Matsuo K, Suzuki T, Kiura K, Tabata M, Takigawa N, Ueoka H, Tanimoto M.

Cancer. 2007 Mar 1;109(5):939-48.

18.

A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).

Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1173-9.

PMID:
11955727
19.

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR; North Central Cancer Treatment Group.

J Clin Oncol. 2003 Sep 1;21(17):3201-6. Epub 2003 Jul 21.

PMID:
12874270
20.

Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.

Birim O, Kappetein AP, Goorden T, van Klaveren RJ, Bogers AJ.

Ann Thorac Surg. 2005 Sep;80(3):1021-6.

PMID:
16122477

Supplemental Content

Support Center